Abstract
Nanosponges are nanosized novel drug delivery systems which are developed by cross linking the polymers with the cross linking agent. The most commonly used polymer is β-cyclodextrin because it is biodegradable and can form nanosponge having crystalline or amorphous porous structure and spherical shape with uniformity. These nanosponges have the ability to encapsulate lipophillic as well as hydrophilic moiety. The release rate of the drug can be modulated by varying the ratio of polymer to cross linking agent. Nanosponges are very minute structures such that they can be used for targeting the drug to the specific site by conjugating the ligands onto their surface. Nanosponges can be employed to enhance the aqueous solubility of poorly water soluble drugs, improve bioavailability, and protect photo sensitive drugs, for sustained release and for site specific drug delivery. Nanosponge technology is also employed in the fields other than pharmacy and medicine like water purification, for pollution free environment, in gas storage and also in agriculture. It is a unique and multifunctional technology, considered to be suitable for the drug delivery.
Keywords: β-cyclodextrin, bioavailability, cross-linking, nanosponge, sustained drug delivery.
Drug Delivery Letters
Title:Nanosponge: A Novel Carrier for Drug Delivery
Volume: 3 Issue: 3
Author(s): Rehana Ansari, Rachna Maheshwari, Shikha Jain, Suresh C. Mahajan and Vikas Jain
Affiliation:
Keywords: β-cyclodextrin, bioavailability, cross-linking, nanosponge, sustained drug delivery.
Abstract: Nanosponges are nanosized novel drug delivery systems which are developed by cross linking the polymers with the cross linking agent. The most commonly used polymer is β-cyclodextrin because it is biodegradable and can form nanosponge having crystalline or amorphous porous structure and spherical shape with uniformity. These nanosponges have the ability to encapsulate lipophillic as well as hydrophilic moiety. The release rate of the drug can be modulated by varying the ratio of polymer to cross linking agent. Nanosponges are very minute structures such that they can be used for targeting the drug to the specific site by conjugating the ligands onto their surface. Nanosponges can be employed to enhance the aqueous solubility of poorly water soluble drugs, improve bioavailability, and protect photo sensitive drugs, for sustained release and for site specific drug delivery. Nanosponge technology is also employed in the fields other than pharmacy and medicine like water purification, for pollution free environment, in gas storage and also in agriculture. It is a unique and multifunctional technology, considered to be suitable for the drug delivery.
Export Options
About this article
Cite this article as:
Ansari Rehana, Maheshwari Rachna, Jain Shikha, C. Mahajan Suresh and Jain Vikas, Nanosponge: A Novel Carrier for Drug Delivery, Drug Delivery Letters 2013; 3 (3) . https://dx.doi.org/10.2174/22103031113039990004
DOI https://dx.doi.org/10.2174/22103031113039990004 |
Print ISSN 2210-3031 |
Publisher Name Bentham Science Publisher |
Online ISSN 2210-304X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Antioxidants and Pro-Antioxidants Network: An Overview
Current Pharmaceutical Design Understanding and Applying Personalized Therapeutics at Systems Level:Role for Translational Bioinformatics
Current Pharmacogenomics and Personalized Medicine Oligonucleotides and G-quadruplex Stabilizers: Targeting Telomeres and Telomerase in Cancer Therapy
Current Pharmaceutical Design The Effects of Mindfulness-Based Interventions on Sleep Disturbance: A Meta-Analysis
Adolescent Psychiatry Propargyl 4-[18F]fluorobenzoate: A Putatively More Stable Prosthetic Group for the Fluorine-18 Labeling of Biomolecules via Click Chemistry
Current Radiopharmaceuticals Cardiovascular and Metabolic Effects of Ghrelin
Current Diabetes Reviews Discovery of Novel CYP17 Inhibitors for the Treatment of Prostate Cancer with Structure-Based Drug Design
Letters in Drug Design & Discovery Zinc Tetrafluoroborate Catalyzed Synthesis, Molecular Docking and Cytotoxicity of Pyrrolidinyl Aminophosphonates
Letters in Drug Design & Discovery Ghrelin as a Potential Anti-Obesity Target
Current Pharmaceutical Design The Emerging Role of Metabotropic Glutamate Receptors in the Pathophysiology of Chronic Stress-Related Disorders
Current Neuropharmacology Protein Homeostasis as a Therapeutic Target for Diseases of Protein Conformation
Current Topics in Medicinal Chemistry P2X Receptors and Inflammation
Current Medicinal Chemistry Tumor Control by Manipulation of the Human Anti-Apoptotic Survivin Gene
Current Cancer Therapy Reviews Expression and Single Nucleotide Polymorphism of Poly (ADPRibose) Polymerase-1 in Gastrointestinal Tumours: Clinical Involvement
Current Medicinal Chemistry Interaction between Gastric and Upper Small Intestinal Hormones in the Regulation of Hunger and Satiety: Ghrelin and Cholecystokinin Take the Central Stage
Current Protein & Peptide Science Extra Virgin Olive Oils Polyphenols: Biological Activities
Current Pharmaceutical Design Cancer Stem Cell Markers in Nasopharyngeal Carcinoma and Its Relevance for Therapy
Current Traditional Medicine Genetically Redirected T Lymphocytes for Adoptive Immunotherapy of Solid Tumors
Current Gene Therapy Key Sites for P2X Receptor Function and Multimerization: Overview of Mutagenesis Studies on a Structural Basis
Current Medicinal Chemistry Thalidomide–A Notorious Sedative to a Wonder Anticancer Drug
Current Medicinal Chemistry